• Explore /
  • Poster
  • / Phase I study of a novel S1P inhibitor, NOX66, in combination with radiotherapy in patients with metastatic castration-resistant prostate cancer.

Phase I study of a novel S1P inhibitor, NOX66, in combination with radiotherapy in patients with metastatic castration-resistant prostate cancer.

Abstract Video & Slides Poster

Authors

null

Paul L. de Souza

University of Western Sydney School of Medicine, Liverpool, Australia

Paul L. de Souza , Anne Louise Capp , Nana Chikhladze , Zaza Mezvrishvili , Marinella Messina , Gisela Mautner

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT03307629

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5533)

DOI

10.1200/JCO.2020.38.15_suppl.5533

Abstract #

5533

Poster Bd #

114

Abstract Disclosures

Similar Posters

First Author: Colin P Bergstrom

First Author: Guilhem Roubaud

First Author: Jones T. Nauseef

First Author: Ray Manneh Kopp